
    
      Eligible individuals were evaluated monthly for 3 months while taking intramuscular
      interferon beta-1a, 30 micrograms weekly, then monthly for 4 months while receiving
      intramuscular interferon beta-1a, 30 micrograms and oral doxycycline, 100 mg daily.
    
  